Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGN-00101 (HspE7) in Women With CIN 3
NCT00054041Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2004
- Primary completion
- Jan 2007
- Modality
- Vaccines & Immunotherapeutics, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of verpasep caltespen in cervical intraepithelial neoplasia (CIN), sponsored by National Cancer Institute. Started Jun 2004; status: completed.
02
Drugs
verpasep caltespen
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT00054041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00054041.